Individualized Obesity Care in Maryland
How Obesity Can Increase Small LDL Particle Number
Obesity often increases the number of small LDL particles, which are more harmful than standard LDL cholesterol. These tiny particles stay longer in circulation, oxidize easily, and fuel artery plaque. Insulin resistance, high triglycerides, low HDL cholesterol, and inflammation all contribute. Advanced lipid testing reveals these hidden risks. Personalized care can reduce weight, improve insulin sensitivity, and shift cholesterol toward a safer pattern for heart health.
Published
Wellness Years vs. Medication Years: Rethinking the Goal
Is stopping medication always the right goal? Not if it sacrifices your long-term health. This article reframes the conversation around therapy and wellness, showing how smart, minimal, safe support can help maintain metabolic gains over time. This writing offers insight into balancing lasting vitality with the least intervention necessary.
Published
Categorized as Diabetes Care, Insights from Dr. Tashko, Metabolic Longevity, Obesity Care, Philosophy & Perspective, Wellness
SUMMIT Trial: Tirzepatide Reduces Heart Failure Risk in Patients with Obesity
The SUMMIT trial investigated how tirzepatide (Mounjaro or Zepbound), a weight-loss medication, affects heart failure with preserved ejection fraction (HFpEF) in patients with obesity. HFpEF, where the heart pumps effectively but struggles to fill properly, is more common in individuals with high body mass index (BMI). Researchers aimed to determine whether tirzepatide could improve cardiovascular outcomes and enhance quality of life for this population.
Published